Vyant Bio Inc reports results for the quarter ended in September - Earnings Summary

Vyant Bio

15/11/2022 15:55

* Vyant Bio Inc  VYNT.OQ  reported a quarterly adjusted loss
of 59
cents​​ per share for the quarter ended in September. The mean
expectation of two analysts for the quarter was for a loss of 70
cents per share.
    * Revenue fell 89.9% to $152.00 thousand from a year ago;
analysts
expected $70.50 thousand. 
    * Vyant Bio Inc's reported EPS for the quarter was a loss
of 59
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vyant Bio Inc shares had fallen by 45.7% this quarter and
lost 77.6% so far this year.
    * The company reported a quarterly loss of $3.46 million.
    * Wall Street's median 12-month price target for Vyant Bio
Inc is
$12.20 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 03:55 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.70          -0.59          Beat
 Jun. 30 2022      -0.75          -1.00          Missed
 Mar. 31 2022      -0.80          -1.60          Missed
 Dec. 31 2021      -0.80          -0.20          Beat